Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 3
1949 1
1950 1
1952 1
1961 1
1964 1
1972 1
1976 1
1981 1
1982 2
1983 1
1984 1
1986 2
1987 5
1988 4
1989 11
1990 17
1991 17
1992 36
1993 63
1994 45
1995 44
1996 53
1997 63
1998 68
1999 60
2000 51
2001 67
2002 51
2003 55
2004 66
2005 87
2006 61
2007 75
2008 83
2009 73
2010 98
2011 88
2012 83
2013 93
2014 91
2015 109
2016 89
2017 83
2018 91
2019 108
2020 101
2021 115
2022 46
Text availability
Article attribute
Article type
Publication date

Search Results

2,162 results
Results by year
Filters applied: . Clear all
Page 1
Angelman Syndrome.
Margolis SS, Sell GL, Zbinden MA, Bird LM. Margolis SS, et al. Neurotherapeutics. 2015 Jul;12(3):641-50. doi: 10.1007/s13311-015-0361-y. Neurotherapeutics. 2015. PMID: 26040994 Free PMC article. Review.
In this review we summarize the clinical and genetic aspects of Angelman syndrome (AS), its molecular and cellular underpinnings, and current treatment strategies. ...
In this review we summarize the clinical and genetic aspects of Angelman syndrome (AS), its molecular and cellular underpinnings, and …
Angelman syndrome - insights into a rare neurogenetic disorder.
Buiting K, Williams C, Horsthemke B. Buiting K, et al. Nat Rev Neurol. 2016 Oct;12(10):584-93. doi: 10.1038/nrneurol.2016.133. Epub 2016 Sep 12. Nat Rev Neurol. 2016. PMID: 27615419 Review.
Angelman syndrome is a rare neurogenetic disorder that is characterized by microcephaly, severe intellectual deficit, speech impairment, epilepsy, EEG abnormalities, ataxic movements, tongue protrusion, paroxysms of laughter, abnormal sleep patterns, and hyperactivity.
Angelman syndrome is a rare neurogenetic disorder that is characterized by microcephaly, severe intellectual deficit, speech impairme
Angelman syndrome: a journey through the brain.
Maranga C, Fernandes TG, Bekman E, da Rocha ST. Maranga C, et al. FEBS J. 2020 Jun;287(11):2154-2175. doi: 10.1111/febs.15258. Epub 2020 Mar 14. FEBS J. 2020. PMID: 32087041 Free article. Review.
Angelman syndrome (AS) is an incurable neurodevelopmental disease caused by loss of function of the maternally inherited UBE3A gene. ...
Angelman syndrome (AS) is an incurable neurodevelopmental disease caused by loss of function of the maternally inherited UBE3A gene.
Angelman Syndrome: Identification and Management.
Bonello D, Camilleri F, Calleja-Agius J. Bonello D, et al. Neonatal Netw. 2017 May 1;36(3):142-151. doi: 10.1891/0730-0832.36.3.142. Neonatal Netw. 2017. PMID: 28494826 Review.
Angelman syndrome (AS) is a neurobehavioral and genetically determined condition, which affects approximately 1 in 15,000 individuals. ...
Angelman syndrome (AS) is a neurobehavioral and genetically determined condition, which affects approximately 1 in 15,000 individuals
Angelman Syndrome.
Madaan M, Mendez MD. Madaan M, et al. 2021 Aug 14. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan–. 2021 Aug 14. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan–. PMID: 32809705 Free Books & Documents.
In 1965 Harry Angelman, a British pediatrician, described the "Puppet Children," later being renamed Angelman syndrome (AS). ...Angelman syndrome is a rare neurogenic disorder. It is a classic example of genomic imprinting, where the expression of a genomic r …
In 1965 Harry Angelman, a British pediatrician, described the "Puppet Children," later being renamed Angelman syndrome (AS). . …
Communication in Angelman syndrome: a scoping review.
Pearson E, Wilde L, Heald M, Royston R, Oliver C. Pearson E, et al. Dev Med Child Neurol. 2019 Nov;61(11):1266-1274. doi: 10.1111/dmcn.14257. Epub 2019 May 10. Dev Med Child Neurol. 2019. PMID: 31074506 Free article. Review.
AIM: A scoping review was conducted to examine and evaluate empirical data on the communication profile of Angelman syndrome beyond the described dissociation between receptive language and speech. ...The use of communicative forms differs between the genetic aetiologies o …
AIM: A scoping review was conducted to examine and evaluate empirical data on the communication profile of Angelman syndrome beyond t …
Genotype-Phenotype Correlations in Angelman Syndrome.
Yang L, Shu X, Mao S, Wang Y, Du X, Zou C. Yang L, et al. Genes (Basel). 2021 Jun 28;12(7):987. doi: 10.3390/genes12070987. Genes (Basel). 2021. PMID: 34203304 Free PMC article. Review.
Angelman syndrome (AS) is a rare neurodevelopmental disease that is caused by the loss of function of the maternal copy of ubiquitin-protein ligase E3A (UBE3A) on the chromosome 15q11-13 region. ...
Angelman syndrome (AS) is a rare neurodevelopmental disease that is caused by the loss of function of the maternal copy of ubiquitin-
Therapies in preclinical and clinical development for Angelman syndrome.
Markati T, Duis J, Servais L. Markati T, et al. Expert Opin Investig Drugs. 2021 Jul;30(7):709-720. doi: 10.1080/13543784.2021.1939674. Epub 2021 Jun 28. Expert Opin Investig Drugs. 2021. PMID: 34112038 Review.
Introduction: Angelman syndrome is a rare genetic neurodevelopmental disorder, caused by deficiency or abnormal function of the maternal ubiquitin protein-ligase E3A, known as UBE3A, in the central nervous system. There is no disease-modifying treatment available, but the …
Introduction: Angelman syndrome is a rare genetic neurodevelopmental disorder, caused by deficiency or abnormal function of the mater …
Angelman syndrome.
Kyllerman M. Kyllerman M. Handb Clin Neurol. 2013;111:287-90. doi: 10.1016/B978-0-444-52891-9.00032-4. Handb Clin Neurol. 2013. PMID: 23622177 Review.
Angelman syndrome combines severe mental retardation, epilepsy, ataxia, speech impairment, and unique behavior with happy demeanor, laughing, short attention span, hyperactivity, and sleep disturbance. ...
Angelman syndrome combines severe mental retardation, epilepsy, ataxia, speech impairment, and unique behavior with happy demeanor, l
Angelman syndrome and melatonin: What can they teach us about sleep regulation.
Buonfiglio D, Hummer DL, Armstrong A, Christopher Ehlen J, DeBruyne JP. Buonfiglio D, et al. J Pineal Res. 2020 Nov;69(4):e12697. doi: 10.1111/jpi.12697. Epub 2020 Oct 11. J Pineal Res. 2020. PMID: 32976638 Free PMC article. Review.
Over the past 50 years, the disorder became Angelman's namesake and symptomology was expanded to include hyper-activity, stereotypies, and severe sleep disturbances. The sleep disorders in many Angelman syndrome (AS) patients are broadly characterized by diff …
Over the past 50 years, the disorder became Angelman's namesake and symptomology was expanded to include hyper-activity, stere …
2,162 results